Conflict of Interest and Medicine (eBook, PDF)
Knowledge, Practices, and Mobilizations
Redaktion: Hauray, Boris; Michel, Hélène; Gaudillière, Jean-Paul; Boullier, Henri
Alle Infos zum eBook verschenken
Conflict of Interest and Medicine (eBook, PDF)
Knowledge, Practices, and Mobilizations
Redaktion: Hauray, Boris; Michel, Hélène; Gaudillière, Jean-Paul; Boullier, Henri
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Hier können Sie sich einloggen
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
In the context of a growing criticism on the influence of the pharmaceutical industry on physicians, scientists or politicians, Conflict of Interest and Medicine offers a comprehensive analysis of conflict of interest in medicine anchored in the social sciences, with perspectives from sociology, history, political science, and law.
- Geräte: PC
- ohne Kopierschutz
- eBook Hilfe
- Größe: 9.27MB
- Conflict of Interest and Medicine (eBook, ePUB)42,95 €
- Tina StevensBiotech Juggernaut (eBook, PDF)39,95 €
- Marie BismarkExperiences of Health Workers in the COVID-19 Pandemic (eBook, PDF)39,95 €
- George F. TomossyHuman Experimentation and Research (eBook, PDF)52,95 €
- Nursing a Radical Imagination (eBook, PDF)42,95 €
- The Elderly (eBook, PDF)42,95 €
- Dominic MalcolmThe Concussion Crisis in Sport (eBook, PDF)40,95 €
-
-
-
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
- Produktdetails
- Verlag: Taylor & Francis
- Seitenzahl: 270
- Erscheinungstermin: 5. September 2021
- Englisch
- ISBN-13: 9781000432367
- Artikelnr.: 62279330
- Verlag: Taylor & Francis
- Seitenzahl: 270
- Erscheinungstermin: 5. September 2021
- Englisch
- ISBN-13: 9781000432367
- Artikelnr.: 62279330
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Part 1. Knowledge and Expertise
1. A Genealogy of Conflict of Interest
2. "Conflict of Interest" or Simply "Interest"? Shifting Values in Translational Medicine
3. Managing Conflicts of Interest at the European Medicines Agency: Success or Weakness of the Soft Law Tools?
4. From the Management of Conflicts of Interest to the Transformation of Medical Experts' Profiles. The Members of the Transparency Committee in France (2000-2020)
Part 2. Physicians and the Framing of Prescription Practices
5. Conflicts of Interest in Medical Practice: Causes and Cures
6. In Whose Best Interest? Framing Pharmacists' and Physicians' (Conflicts of) Interest in the French Market for Generic Drugs
7. The Politics of Industrial Transparency. Constructing a Database on the Pharmaceutical Funding of the Health Sector
8. Scientific Marketing and Conflict of Interest: Lessons From the Hormone Replacement Therapies (HRT) Crisis
Part 3. Mobilizations and Controversies
9. "This Corporation Has 'Anesthetized' the Actors in the Drug Chain". Influence Peddling and the Normality of Conflicts of Interest in the Mediator® Scandal
10. For Science, by Science. The Emergence and Circulation of Conflict of Interest as a Protest Repertoire to Fight Against Pesticides
11. Conflict of interest, Capture, Production of Ignorance, and Hegemony: Conceptualizing the Influence of Corporate Interests on Public Health
Postface: Conflict of Interest, Industry Hegemony and Key Opinion Leader Management
Part 1. Knowledge and Expertise
1. A Genealogy of Conflict of Interest
2. "Conflict of Interest" or Simply "Interest"? Shifting Values in Translational Medicine
3. Managing Conflicts of Interest at the European Medicines Agency: Success or Weakness of the Soft Law Tools?
4. From the Management of Conflicts of Interest to the Transformation of Medical Experts' Profiles. The Members of the Transparency Committee in France (2000-2020)
Part 2. Physicians and the Framing of Prescription Practices
5. Conflicts of Interest in Medical Practice: Causes and Cures
6. In Whose Best Interest? Framing Pharmacists' and Physicians' (Conflicts of) Interest in the French Market for Generic Drugs
7. The Politics of Industrial Transparency. Constructing a Database on the Pharmaceutical Funding of the Health Sector
8. Scientific Marketing and Conflict of Interest: Lessons From the Hormone Replacement Therapies (HRT) Crisis
Part 3. Mobilizations and Controversies
9. "This Corporation Has 'Anesthetized' the Actors in the Drug Chain". Influence Peddling and the Normality of Conflicts of Interest in the Mediator® Scandal
10. For Science, by Science. The Emergence and Circulation of Conflict of Interest as a Protest Repertoire to Fight Against Pesticides
11. Conflict of interest, Capture, Production of Ignorance, and Hegemony: Conceptualizing the Influence of Corporate Interests on Public Health
Postface: Conflict of Interest, Industry Hegemony and Key Opinion Leader Management